Eligibility Criteria for Cholecystectomy in Ambulatory Surgery

May 30, 2018 updated by: Pierre Wauthy

Cold laparoscopic cholecystectomy is the gold standard for the management of symptomatic vesicular stones. There is considerable controversy as to whether it should be practiced in outpatient surgery or as part of inpatient surgery, regarding to patient safety.

"Minor" surgical procedures, such as anal surgery or simple inguinal hernia interventions, were initially considered eligible for an outpatient procedure. Advances in surgical techniques, anesthesia and early rehabilitation have also made it possible to consider more "heavy" interventions, such as cholecystectomy.

The aim of this study is to identify eligible patients for laparoscopic cholecystectomy in outpatient surgery, taking surgical criteria into account.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium, 1020
        • CHU Brugmann

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who have had a laparoscopic cholecystectomy with a single cholecystectomy procedure without other associated interventions (bariatric surgery or other). Hospitalisation within the CHU Brugmann Hospital between May 2016 and November 2017.

Description

Inclusion Criteria:

  • Patients who have had a laparoscopic cholecystectomy with a single cholecystectomy procedure without other associated interventions (bariatric surgery or other)

Exclusion Criteria:

  • Pregnant women
  • Diabetic patients under insulin treatment
  • History of major abdominal surgery
  • Acute cholecystitis as per anatomo-pathological examination

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cholecystectomy
Patients with a symptomatic vesicular lithiasis, having undergone cholecystectomy during a scheduled hospitalization in the CHU Brugmann Hospital between May 2016 and November 2017.
Cholecystectomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgery duration
Time Frame: Up to 4h
Duration of the surgical intervention
Up to 4h
Post surgical pain
Time Frame: Up to 1 day after surgery
Pain killer medication administered post surgery, expressed in mg
Up to 1 day after surgery
Nausea
Time Frame: Up to 1 day after surgery
Occurence of nausea or vomiting post surgery
Up to 1 day after surgery
Post surgery hospitalization duration
Time Frame: Up to 10 days after surgery
Post surgery hospitalization duration
Up to 10 days after surgery
Medical complications after surgery
Time Frame: Up to 1 year after surgery
Medical complications after surgery
Up to 1 year after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Data extraction from medical files: medical history
Time Frame: 5 min
Important surgical or medical antecedents of the patient before surgery (data extraction from medical file).
5 min
Physical status score
Time Frame: 5 min
Physical status score (also called ASA score for American Society of Anesthesiologists score) of the patient before surgery. The ASA score ranges from I (normal healthy patient) to VI (declared brain-dead patient whose organs are being removed for donor purposes)
5 min
Body mass index
Time Frame: 5 min
Body mass index of the patient before surgery
5 min
Hospitalisation type
Time Frame: Up to 10 days after surgery
Same day (ambulatory) or not
Up to 10 days after surgery
Type of surgery
Time Frame: Up to 4 hours
Surgery performed under nuclear magnetic resonance (RMN) or RMN + endoscopic retrograde cholangiography (CWR)
Up to 4 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Levon HAKOBYAN, CHU Brugmann

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 21, 2017

Primary Completion (Actual)

February 27, 2018

Study Completion (Actual)

February 27, 2018

Study Registration Dates

First Submitted

January 11, 2018

First Submitted That Met QC Criteria

January 17, 2018

First Posted (Actual)

January 18, 2018

Study Record Updates

Last Update Posted (Actual)

May 31, 2018

Last Update Submitted That Met QC Criteria

May 30, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • CHUB-cholecystectomy

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cholecystectomy

Clinical Trials on Cholecystectomy

3
Subscribe